You are requesting information on: Theravance Announces Initiation Of Phase 2b Study With Its LAMA Candidate TD-4208 For The Treatment Of COPD
Already a member of Pharmaceutical Online or VertMarkets? Sign in now.
In order for our suppliers to better serve your request, please enter specific requirements or questions below: